Joerger, Markus
Stathis, Anastasios
Metaxas, Yannis
Hess, Dagmar
Mantiero, Mara
Mark, Michael
Volden, Matthias
Kaindl, Thomas
Engelhardt, Marc
Larger, Patrice
Lane, Heidi
Hafner, Peter
Levy, Nicole
Stuedeli, Silvia
Sessa, Cristiana
von Moos, Roger
Funding for this research was provided by:
Basilea Pharmaceutica International Ltd
Article History
Received: 10 July 2019
Accepted: 21 August 2019
First Online: 30 August 2019
Compliance with ethical standards
:
: Author MJ declares that he has no conflict of interest. Author AS declares that he has no conflict of interest. Author YM declares that he has no conflict of interest. Author DH declares that she has no conflict of interest. Author MaM declares that she has no conflict of interest. Author MiM declares that he has no conflict of interest. Author MV declares that he has no conflict of interest. Author TK declares that he is an employee of Basilea Pharmaceutica International Ltd. Author ME declares that he is an employee of Basilea Pharmaceutica International Ltd. Author PL declares that he is an employee of Basilea Pharmaceutica International Ltd. Author HL declares that she is an employee of Basilea Pharmaceutica International Ltd. Author PH declares that he is an employee of Basilea Pharmaceutica International Ltd. Author NL declares that she has no conflict of interest. Author SS declares that she has no conflict of interest. Author CS declares that she has no conflict of interest. Author RvM declares that he has no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.